BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 30107216)

  • 1. CYP46A1 protects against NMDA-mediated excitotoxicity in Huntington's disease: Analysis of lipid raft content.
    Boussicault L; Kacher R; Lamazière A; Vanhoutte P; Caboche J; Betuing S; Potier MC
    Biochimie; 2018 Oct; 153():70-79. PubMed ID: 30107216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington's disease.
    Boussicault L; Alves S; Lamazière A; Planques A; Heck N; Moumné L; Despres G; Bolte S; Hu A; Pagès C; Galvan L; Piguet F; Aubourg P; Cartier N; Caboche J; Betuing S
    Brain; 2016 Mar; 139(Pt 3):953-70. PubMed ID: 26912634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP46A1 gene therapy deciphers the role of brain cholesterol metabolism in Huntington's disease.
    Kacher R; Lamazière A; Heck N; Kappes V; Mounier C; Despres G; Dembitskaya Y; Perrin E; Christaller W; Sasidharan Nair S; Messent V; Cartier N; Vanhoutte P; Venance L; Saudou F; Néri C; Caboche J; Betuing S
    Brain; 2019 Aug; 142(8):2432-2450. PubMed ID: 31286142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P38 MAPK is involved in enhanced NMDA receptor-dependent excitotoxicity in YAC transgenic mouse model of Huntington disease.
    Fan J; Gladding CM; Wang L; Zhang LY; Kaufman AM; Milnerwood AJ; Raymond LA
    Neurobiol Dis; 2012 Mar; 45(3):999-1009. PubMed ID: 22198502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PGC-1α negatively regulates extrasynaptic NMDAR activity and excitotoxicity.
    Puddifoot C; Martel MA; Soriano FX; Camacho A; Vidal-Puig A; Wyllie DJ; Hardingham GE
    J Neurosci; 2012 May; 32(20):6995-7000. PubMed ID: 22593067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease.
    Zeron MM; Hansson O; Chen N; Wellington CL; Leavitt BR; Brundin P; Hayden MR; Raymond LA
    Neuron; 2002 Mar; 33(6):849-60. PubMed ID: 11906693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-Type Specific Regulation of Cholesterogenesis by CYP46A1 Re-Expression in zQ175 HD Mouse Striatum.
    Pinchaud K; Masson C; Dayre B; Mounier C; Gilles JF; Vanhoutte P; Caboche J; Betuing S
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calpain and STriatal-Enriched protein tyrosine phosphatase (STEP) activation contribute to extrasynaptic NMDA receptor localization in a Huntington's disease mouse model.
    Gladding CM; Sepers MD; Xu J; Zhang LY; Milnerwood AJ; Lombroso PJ; Raymond LA
    Hum Mol Genet; 2012 Sep; 21(17):3739-52. PubMed ID: 22523092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered cholesterol homeostasis contributes to enhanced excitotoxicity in Huntington's disease.
    del Toro D; Xifró X; Pol A; Humbert S; Saudou F; Canals JM; Alberch J
    J Neurochem; 2010 Oct; 115(1):153-67. PubMed ID: 20663016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cholesterol 24-hydroxylase activates autophagy and decreases mutant huntingtin build-up in a neuroblastoma culture model of Huntington's disease.
    Nóbrega C; Conceição A; Costa RG; Koppenol R; Sequeira RL; Nunes R; Carmo-Silva S; Marcelo A; Matos CA; Betuing S; Caboche J; Cartier N; Alves S
    BMC Res Notes; 2020 Apr; 13(1):210. PubMed ID: 32276655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of postsynaptic density protein-95 with NMDA receptors influences excitotoxicity in the yeast artificial chromosome mouse model of Huntington's disease.
    Fan J; Cowan CM; Zhang LY; Hayden MR; Raymond LA
    J Neurosci; 2009 Sep; 29(35):10928-38. PubMed ID: 19726651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation of huntingtin at Ser421 in YAC128 neurons is associated with protection of YAC128 neurons from NMDA-mediated excitotoxicity and is modulated by PP1 and PP2A.
    Metzler M; Gan L; Mazarei G; Graham RK; Liu L; Bissada N; Lu G; Leavitt BR; Hayden MR
    J Neurosci; 2010 Oct; 30(43):14318-29. PubMed ID: 20980587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitigation of augmented extrasynaptic NMDAR signaling and apoptosis in cortico-striatal co-cultures from Huntington's disease mice.
    Milnerwood AJ; Kaufman AM; Sepers MD; Gladding CM; Zhang L; Wang L; Fan J; Coquinco A; Qiao JY; Lee H; Wang YT; Cynader M; Raymond LA
    Neurobiol Dis; 2012 Oct; 48(1):40-51. PubMed ID: 22668780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutant huntingtin and glycogen synthase kinase 3-beta accumulate in neuronal lipid rafts of a presymptomatic knock-in mouse model of Huntington's disease.
    Valencia A; Reeves PB; Sapp E; Li X; Alexander J; Kegel KB; Chase K; Aronin N; DiFiglia M
    J Neurosci Res; 2010 Jan; 88(1):179-90. PubMed ID: 19642201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restored Fyn Levels in Huntington's Disease Contributes to Enhanced Synaptic GluN2B-Composed NMDA Receptors and CREB Activity.
    Fão L; Coelho P; Rodrigues RJ; Rego AC
    Cells; 2022 Sep; 11(19):. PubMed ID: 36231023
    [No Abstract]   [Full Text] [Related]  

  • 16. Altered NMDA receptor trafficking in a yeast artificial chromosome transgenic mouse model of Huntington's disease.
    Fan MM; Fernandes HB; Zhang LY; Hayden MR; Raymond LA
    J Neurosci; 2007 Apr; 27(14):3768-79. PubMed ID: 17409241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective neuronal degeneration in Huntington's disease.
    Cowan CM; Raymond LA
    Curr Top Dev Biol; 2006; 75():25-71. PubMed ID: 16984809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease.
    Fan MM; Raymond LA
    Prog Neurobiol; 2007 Apr; 81(5-6):272-93. PubMed ID: 17188796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in N-methyl-D-aspartate receptor sensitivity and magnesium blockade occur early in development in the R6/2 mouse model of Huntington's disease.
    Starling AJ; André VM; Cepeda C; de Lima M; Chandler SH; Levine MS
    J Neurosci Res; 2005 Nov; 82(3):377-86. PubMed ID: 16211559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutant huntingtin enhances excitotoxic cell death.
    Zeron MM; Chen N; Moshaver A; Lee AT; Wellington CL; Hayden MR; Raymond LA
    Mol Cell Neurosci; 2001 Jan; 17(1):41-53. PubMed ID: 11161468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.